Intuitive Surgical (ISRG) Tops Q3 EPS by 20c

Go back to Intuitive Surgical (ISRG) Tops Q3 EPS by 20c

Intuitive Surgical (ISRG) PT Raised to $555 at RBC Capital

October 18, 2024 7:06 AM UTC

RBC Capital analyst Shagun Singh raised the price target on Intuitive Surgical (NASDAQ: ISRG) to $555.00 (from $525.00) while maintaining a Outperform rating.

The analyst comments "ISRG reported Q324 results, delivering upside surprise of 2% on sales, driven by robust procedure volume growth (+18% or 17% y/y day-adjusted vs.... More

Truist Securities Reiterates Buy Rating on Intuitive Surgical (ISRG)

October 18, 2024 5:53 AM UTC

Truist Securities analyst Richard Newitter reiterated a Buy rating and $570.00 price target on Intuitive Surgical (NASDAQ: ISRG).

The analyst comments "ISRG delivered 3Q rev/EPS upside as growth accelerated both on sales & EPS. The qtr saw a big US system beat (incl... More

Intuitive Surgical (ISRG) PT Raised to $490 at Evercore ISI

October 18, 2024 5:45 AM UTC

Evercore ISI analyst Vijay Kumar raised the price target on Intuitive Surgical (NASDAQ: ISRG) to $490.00 (from $475.00) while maintaining a In Line rating.

The analyst comments "Thesis Update: ISRG reported ~17% YoY rev growth (total revs 1.6% above ST), driven by 4% Systems rev Beat & ~1.8% Consumable rev beat. On the system side, total placements of ~379 came in 12% above ST, driven by a sizeable US Beat (219 placements came in 37% above our est of 160) and was partly offset by OUS (10% below EVR on EU & China softness). Total dV5 placements of 110 was up QoQ from 70 placements in... More

Intuitive Surgical (ISRG) PT Raised to $535 at BTIG

October 18, 2024 5:41 AM UTC

BTIG analyst Ryan Zimmerman raised the price target on Intuitive Surgical (NASDAQ: ISRG) to $535.00 (from $518.00) while maintaining a Buy rating.

The analyst comments "We reiterate our Buy and raise our PT to $535 (from $518 PT) following 3Q24 results. ISRG reported revenue of $2.038B (16.9% Y/Y) and... More